Entasis Therapeutics Holdings Inc.
ETTX
ETTX was delisted on the 8th of July, 2022.
24 hedge funds and large institutions have $8.89M invested in Entasis Therapeutics Holdings Inc. in 2021 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 8 closing their positions.
5% less capital invested
Capital invested by funds: $9.34M → $8.89M (-$449K)
4% less funds holding
Funds holding: 25 → 24 (-1)
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$485K |
| 2 |
Two Sigma Advisers
New York
|
+$368K |
| 3 |
AIMCA
Alberta Investment Management Corp (AIMCo)
Edmonton,
Alberta, Canada
|
+$294K |
| 4 |
Two Sigma Investments
New York
|
+$282K |
| 5 |
State Street
Boston,
Massachusetts
|
+$88.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PBPIA
Pivotal bioVenture Partners Investment Advisor
San Francisco,
California
|
-$2.52M |
| 2 |
Renaissance Technologies
New York
|
-$892K |
| 3 |
Squarepoint
New York
|
-$196K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$147K |
| 5 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
-$44.7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GIM
26
Granahan Investment Management
Waltham,
Massachusetts
| – | -$22K | -10,064 | Closed |
|
27
Federated Hermes
Pittsburgh,
Pennsylvania
| – | -$1K | -566 | Closed |
|
28
Fidelity Investments
Boston,
Massachusetts
| – | +$2 | +1 | New |
|
29
UBS Group
Zurich,
Switzerland
| – | +$233 | +103 | New |
|
ETTX Hedge Fund Activity: Q2 2021 in Review
24 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Entasis Therapeutics Holdings Inc. (ETTX) for Q2 2021, worth a combined $8.89M — down 4.8% from $9.34M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of ETTX and 7 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 4 added.
The largest buyer was Vanguard Group, adding an estimated $485K. The largest seller was Pivotal bioVenture Partners Investment Advisor, exiting entirely with an estimated $2.52M sold.
- 24 institutional investors held Entasis Therapeutics Holdings Inc. (ETTX) as of Q2 2021, down from 25 in Q1 2021.
- Funds reported $8.89M of Entasis Therapeutics Holdings Inc. stock for Q2 2021, down 4.8% quarter-over-quarter.
- 7 funds opened new Entasis Therapeutics Holdings Inc. positions in Q2 2021 and 8 closed out, a net change of -1 holder.
- The largest Entasis Therapeutics Holdings Inc. buyer in Q2 2021 was Vanguard Group, an estimated $485K added.
- The largest Entasis Therapeutics Holdings Inc. seller in Q2 2021 was Pivotal bioVenture Partners Investment Advisor, an estimated $2.52M sold.
Based on aggregated 13F filings for Q2 2021.